JPRN-UMIN000015872已完成2 期
Effect and safety of pregabalin and duloxetine on chemotherapy-related peripheral neurotoxicity for patients with advanced gastric and breast cancer. - Effect and safety of pregabalin and duloxetine on chemotherapy-related peripheral neurotoxicity for patients with advanced gastric and breast cancer
Osaka Medical College Hospital0 个研究点目标入组 60 人开始时间: 2014年12月8日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Serious drug allergy 2) Active double cancer 3) Active infection 4) Serious coexisting illness 5) History of pregabalin and duloxetine treatment 6) Severe renal dysfunction (Creatinine clearance <30mL/min) 7) Patients with using electronic implants or other cardiac pacemaker 8) Pregnant or lactating women or men who have desire father a child 9) Investigator's judgement
研究者
相似试验
招募中
3 期
Effect of duloxetine and pregabalin on invalidation in fibromyalgia.Invalidation in patient with fibromyalgia.M79.7FibromyalgiaIRCT20181113041646N1Rasht University of Medical Sciences68
进行中（未招募）
1 期
Efficacy of pregabalin and duloxetine in patients with painful diabetic peripheral neuropathy (PDPN): the effect of pain on cognitive function, sleep and quality of life (BLOSSOM)The purpose of the trial is to assess the efficacy of Pragiola®(pregabalin) and Dulsevia® (duloxetin) in patients with PDPN,investigate the effect of Pragiola® and Dulsevia® on pain and on qualityof life (QOL), depression symptoms, cognitive functions, sleep qualityand daytime sleepiness and assess the safety of Pragiola® andDulsevia® in patients with PDPN.EUCTR2017-004341-24-PLKRKA, d.d., Novo mesto310
进行中（未招募）
1 期
Efficacy of pregabalin and duloxetine in patients with painful diabetic peripheral neuropathy (PDPN): the effect of pain on cognitive function, sleep and quality of life (BLOSSOM)EUCTR2017-004341-24-HRKrka, d.d., Novo mesto310
进行中（未招募）
1 期
Efficacy of pregabalin and duloxetine in patients with painful diabetic peripheral neuropathy (PDPN): the effect of pain on cognitive function, sleep and quality of life (BLOSSOM)The purpose of the trial is to assess the efficacy of Pregabalin Krka (pregabalin) and Dulsevia® (duloxetin) in patients with PDPN, investigate the effect of Pregabalin Krka and Dulsevia® on pain and on quality of life (QOL), depression symptoms, cognitive functions, sleep quality and daytime sleepiness and assess the safety of Pregabalin Krka and Dulsevia® in patients with PDPN.EUCTR2017-004341-24-SIKrka, d.d., Novo Mesto310
已完成
不适用
Identification of the probable mechanisms of Duloxetine and Pregabalin involving in treatment of neuropathic pain of type 2 diabetic patientsCondition 1: Non-insulin-dependent diabetes mellitus. Condition 2: Pain due to diabetic polyneuropathy. Condition 3: Autonomic neuropathy.Non-insulin-dependent diabetes mellitusDiabetic polyneuropathyAutonomic neuropathy in endocrine and metabolic diseasesG63.2*IRCT2017012932277N1The vice chancellor for research affairs of Shahid Beheshti University of Medical Sciences60